Mark Way's most recent trade in AMC Entertainment Holdings Inc - Ordinary Shares - Class A was a trade of 157,136 CLASS A COMMON STOCK done . Disclosure was reported to the exchange on Feb. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AMC Entertainment Holdings Inc (Class A) | Mark Way | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2026 | 157,136 | 285,069 (0%) | 0% | 0 | CLASS A COMMON STOCK | |
| AMC Entertainment Holdings Inc (Class A) | Mark Way | EXECUTIVE VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 27 Feb 2026 | 73,854 | 211,215 (0%) | 0% | 0 | CLASS A COMMON STOCK | |
| Cineverse Corp (Class A) | Mark Wayne Lindsey | CFO | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 17 Feb 2026 | 35,000 | 154,168 (0%) | 0% | 2 | 70,000 | Class A Common Stock |
| AMC Entertainment Holdings Inc (Class A) | Mark Way | EXECUTIVE VICE PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2026 | 78,569 | 164,861 (0%) | 0% | 0 | CLASS A COMMON STOCK | |
| AMC Entertainment Holdings Inc (Class A) | Mark Way | EXECUTIVE VICE PRESIDENT | 08 Jan 2026 | 42,759 | 85,520 | - | - | RESTRICTED STOCK UNITS | ||
| AMC Entertainment Holdings Inc (Class A) | Mark Way | EXECUTIVE VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 08 Jan 2026 | 36,928 | 127,933 (0%) | 0% | 0 | CLASS A COMMON STOCK | |
| AMC Entertainment Holdings Inc (Class A) | Mark Way | EXECUTIVE VICE PRESIDENT | 08 Jan 2026 | 31,579 | 31,579 | - | - | RESTRICTED STOCK UNITS | ||
| AMC Entertainment Holdings Inc (Class A) | Mark Way | EXECUTIVE VICE PRESIDENT | 08 Jan 2026 | 4,231 | 0 | - | - | RESTRICTED STOCK UNITS | ||
| Edwards Lifesciences | Wayne Markowitz | CVP, JAPAC | Sale of securities on an exchange or to another person at price $ 86.01 per share. | 08 Dec 2025 | 583 | 17,562 (0%) | 0% | 86.0 | 50,144 | Common Stock |
| Cineverse Corp (Class A) | Mark Wayne Lindsey | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2025 | 70,809 | 70,809 | - | - | Restricted Stock Unit | |
| Cineverse Corp (Class A) | Mark Wayne Lindsey | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2025 | 71,699 | 71,699 | - | - | Restricted Stock Unit | |
| Edwards Lifesciences | Wayne Markowitz | CVP, JAPAC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2025 | 6,410 | 18,795 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Wayne Markowitz | CVP, JAPAC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.57 per share. | 11 Sep 2025 | 650 | 18,145 (0%) | 0% | 77.6 | 50,421 | Common Stock |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 17,100 | 17,100 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 3,350 | 3,350 | - | - | Performance Rights | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 3,350 | 12,349 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.92 per share. | 07 May 2025 | 300 | 8,999 (0%) | 0% | 74.9 | 22,476 | Common Stock |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Sale of securities on an exchange or to another person at price $ 75.08 per share. | 07 May 2025 | 268 | 9,299 (0%) | 0% | 75.1 | 20,121 | Common Stock |
| Cineverse Corp (Class A) | Mark Wayne Lindsey | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 33,333 | 151,964 (0%) | 0% | - | Class A Common Stock | |
| Cineverse Corp (Class A) | Mark Wayne Lindsey | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2025 | 33,333 | 66,667 | - | - | Restricted Stock Unit | |
| Cineverse Corp (Class A) | Mark Wayne Lindsey | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.00 per share. | 25 Apr 2025 | 32,796 | 119,168 (0%) | 0% | 3 | 98,388 | Class A Common Stock |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Sale of securities on an exchange or to another person at price $ 73.27 per share. | 06 Dec 2024 | 583 | 9,493 (0%) | 0% | 73.3 | 42,716 | Common Stock |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.52 per share. | 14 Sep 2024 | 648 | 10,033 (0%) | 0% | 68.5 | 44,401 | Common Stock |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 17,800 | 17,800 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 3,350 | 3,350 | - | - | Performance Rights | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 3,350 | 10,648 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2023 | 19,256 | 19,256 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Wayne Markowitz | GM & SVP, Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2023 | 7,262 | 7,262 (0%) | 0% | 0 | Common Stock |